NCT00530192View on ClinicalTrials.gov

Molecular Profiling Protocol (SCRI-CA-001)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Refractory Cancer
Interventions
OTHER

Treatment based on Molecular Profiling

Treatment with commercially available treatments (per package insert instructions)

Trial Locations (9)

29605

Cancer Center of the Carolinas, Greenville

35805

Oncology Specialties, Huntsville

46227

Central Indiana Cancer Center, Indianapolis

75702

Tyler Cancer Center, Tyler

78229

South Texas Oncology Hematology, San Antonio

85258

TGen Clinical Research Services, Scottsdale

85259

Mayo Clinic, Scottsdale

90048

Louis Warschaw Prostate Cancer Center at Cedars Sinai Medical Center, Los Angeles

90211

Tower Oncology, Beverly Hills

All Listed Sponsors
collaborator

Translational Genomics Research Institute

OTHER

lead

Scottsdale Healthcare

OTHER

NCT00530192 - Molecular Profiling Protocol (SCRI-CA-001) | Biotech Hunter | Biotech Hunter